BRIDGEWAY CAPITAL MANAGEMENT, LLC - THERAGENICS CORP ownership

THERAGENICS CORP's ticker is TGX and the CUSIP is 883375107. A total of 41 filers reported holding THERAGENICS CORP in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of THERAGENICS CORP
ValueSharesWeighting
Q3 2013$297,000
-25.2%
136,335
-29.0%
0.01%
-37.5%
Q2 2013$397,000191,9400.02%
Other shareholders
THERAGENICS CORP shareholders Q3 2013
NameSharesValueWeighting ↓
Cannell Capital 731,400$1,514,0000.90%
DAFNA Capital Management LLC 160,719$333,0000.49%
TOURADJI CAPITAL MANAGEMENT, LP 47,500$98,0000.37%
RBF Capital, LLC 291,012$602,0000.17%
Ancora Advisors LLC 329,033$681,0000.12%
HARVEST MANAGEMENT LLC 30,000$62,0000.09%
ALGERT GLOBAL LLC 89,833$186,0000.06%
Spark Investment Management LLC 35,900$74,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 191,940$397,0000.02%
Renaissance Technologies 1,618,300$3,350,0000.01%
View complete list of THERAGENICS CORP shareholders